These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8861048)

  • 1. Consequences of current patterns of Pap smear and colposcopy use.
    Kavanagh AM; Santow G; Mitchell H
    J Med Screen; 1996; 3(1):29-34. PubMed ID: 8861048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
    Budge M; Halford J; Haran M; Mein J; Wright G
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
    Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
    Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear.
    Kavanagh AM; Simpson JM
    Aust N Z J Public Health; 1996 Jun; 20(3):266-71. PubMed ID: 8768416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
    Tavasoli SM; Kane E; Kupets R
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.
    Miller SM; Tagai EK; Wen KY; Lee M; Hui SA; Kurtz D; Scarpato J; Hernandez E
    Patient Educ Couns; 2017 Jul; 100(7):1353-1359. PubMed ID: 28190541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Pap smear follow-up in a high-risk population.
    Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of media reporting of cervical cancer in a UK celebrity on a population-based cervical screening programme.
    MacArthur GJ; Wright M; Beer H; Paranjothy S
    J Med Screen; 2011; 18(4):204-9. PubMed ID: 22156146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening in Western Australia in 1992: progress since 1983.
    Straton JA; Holman CD; Edwards BM
    Med J Aust; 1993 Nov; 159(10):657-61. PubMed ID: 8232008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.